ASPI NASDAQ
Credit Risk of going bust: higher than 92% of companies Debt: 46.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.29 (down 86%), ASP Isotopes Inc. Common Stock would be worth roughly what it owes.
Total debt $269.6M against a stock market value of $309.7M.
Distance to default 1.27 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $159.9M (short-term plus half of long-term), stock volatility 98.4%; Altman Z -0.36. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Dallas, TX 75201
US
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kiessling Heather | S-Sale | 21,830 | $2.19 | 2026-10-16 |
| Ainscow Robert | S-Sale | 22,500 | $2.11 | 2026-10-14 |
| Ryan Robert John And | P-Purchase | 15,000 | $2.68 | 2026-09-30 |
| Ryan Robert John And | P-Purchase | 8,000 | $2.70 | 2026-09-28 |
| Ainscow Robert | S-Sale | 8,438 | $4.29 | 2026-09-08 |